-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
- Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $60.8K.
- Protagenic Therapeutics, Inc.\new Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$354K, a 4261% decline year-over-year.
- Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2023 was -$474K, a 20841% decline from 2022.
- Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2022 was $2.28K.
- Protagenic Therapeutics, Inc.\new annual Nonoperating Income (Expense) for 2021 was -$383K, a 13400% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)